What You Need to Know About Bipolar Depression
You must understand that bipolar disorder is a kind of condition which affects all types of individuals. Both children and adults would get affected by such kind of condition. This is one fact that you must understand. The women are going to suffer the most from such type of depression which is called bipolar depression disorder.
This is not really strange or far-fetched in any case because even if the women would suffer from the regular bipolar type of depression or depressive disorder, they are going to spend more time depressed than they would do being manic. Not only women are depressive but the men also are and they could also be affected by this condition.
Such bipolar kind of disorder is called manic depression since such is one mental condition in which you would interchange often between the phases of mania as well as depression. When you suffer from bipolar depression, you will not have to spend as much time being manic as you spend being depressed.
This kind of depression is one form of disorder and you should understand it is easy to wrongly diagnose as bipolar disorder due to the similarity of such symptoms. Because of this, the doctor must have to keep you around for a long time when they would try to diagnose the condition that you have. It is definitely not flattering to either of you if you would be treated for a wrong thing.
The bipolar affective disorder is simply another name for such bipolar disorder or the manic-depressive illness. But, you don’t like to mistake this for bipolar depression disorder. This is closely related with the symptoms of the depressive phase of the bipolar disorder but just a few of the mania.
The monotherapy trials against the placebo continue to be the gold-standard design when it comes to determining the efficacy in bipolar depression. If the efficacy would get proven as monotherapy, those new compounds can be tested in the adjunctive-medication placebo-controlled trials. Those younger adults, without the established need for such long-term medication can be suitable for the clinical trials needing placebo-controls. The switch to mania or hypomania can be the consequence of such active treatment for the bipolar depression.
Some of the medications like the tricyclic antidepressants as well as venlafaxine can be more likely to prove switch than the others but the increased rate of the switch cannot be seen until around ten weeks of treatment. Hence, the 12-week trials against placebo are required to determine such risk of switch and to establish such continuing effects. Know that such careful assessments at six to eight weeks are needed to ensure that the patients who fail to respond don’t continue in the study for such unacceptable periods of time.